Modulation of peroxisome proliferator-activated receptor δ activity affects neural cell adhesion molecule and polysialyltransferase ST8SiaIV induction by teratogenic valproic acid analogs in F9 cell differentiation

Molecular Pharmacology

Volumn 68, Issue 1, 2005, Pages 193-203

  Lampen, Alfonso ^a   Grimaldi, Paul A ^b   Nau, Heinz ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^b CENTRE DE BIOCHIMIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; NERVE CELL ADHESION MOLECULE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; POLYSIALIC ACID; POLYSIALYLTRANSFERASE; TRANSFERASE; TRICHOSTATIN A; UNCLASSIFIED DRUG; VALPROIC ACID;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL SELECTION; CONTROLLED STUDY; GENE IDENTIFICATION; GENETIC TRANSFECTION; MOUSE; NERVE CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TERATOGENICITY;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; ENZYME INDUCTION; MICE; NEURAL CELL ADHESION MOLECULES; PPAR DELTA; SIALYLTRANSFERASES; TERATOGENS; VALPROIC ACID;

EID: 22344445660     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.009340     Document Type: Article

References (40)

1. Alonso A, Breuer B, Steuer B, and Fischer J (1991) The F9-EC cell line as a model for the analysis of differentiation. Int J Dev Biol 35:389-397.
2. Amri EZ, Bonino F, Ailhaud G, Abumrad NA, and Grimaldi PA (1995) Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors. J Biol Chem 270:2367-2371.
3. Auboeuf D, Rieusset J, Fajas L, Vallier P, Frering V, Riou JP, Staels B, Auwerx J, Laville M, and Vidal H (1997) Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients. Diabetes 46:1319-1327.
4. Barthels D, Santoni MJ, Wille W, Ruppert C, Chaix JC, Hirsch MR, Fontecilla-Camps JC, and Goridis C (1987) Isolation and nucleotide sequence of mouse NCAM cDNA that codes for a Mr 79,000 polypeptide without a membrane-spanning region. EMBO (Eur Mol Biol Organ) J 6:907-914.
5. Barton CH, Mann DA, and Walsh FS (1990) Characterization of the human N-CAM promoter. Biochem J 268:161-168.
6. Bastie C, Luquet S, Holst D, Jehl-Pietri C, and Grimaldi PA (2000) Alterations of peroxisome proliferator-activated receptor delta activity affect fatty acid-controlled adipose differentiation. J Biol Chem 275:38768-38773.
7. Bojic U, Ehlers K, Ellerbeck U, Bacon CL, O'Driscoll E, O'Connell C, Berezin V, Kawa A, Lepekhin E, Bock E, et al. (1998) Studies on the teratogen pharmacophore of valproic acid analogues: evidence of interactions at a hydrophobic centre. Eur J Pharmacol 354:289-299.
8. Bojic U, Elmazar MM, Hauck RS, and Nau H (1996) Further branching of valproaterelated carboxylic acids reduces the teratogenic activity, but not the anticonvulsant effect. Chem Res Toxicol 9:866-870.
9. Cinatl J Jr, Cinatl J, Scholz M, Driever PH, Henrich D, Kabickova H, Vogel JU, Doerr HW, and Kornhuber B (1996) Antitumor activity of sodium valproate in cultures of human neuroblastoma cells. Anticancer Drugs 7:766-773.
10. Eckhardt M and Gerardy-Schahn R (1998) Genomic organization of the murine polysialyltransferase gene ST8SiaIV (PST-1). Glycobiology 8:1165-1172.
11. Ehlers K, Sturje H, Merker HJ, and Nau H (1992) Valproic acid-induced spina bifida: a mouse model. Teratology 45:145-154.
12. Forman BM, Chen J, and Evans RM (1997) Hypolipidemic drugs, polyunsaturated fatty acids and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 94:4312-4317.
13. Goridis C and Brunet JF (1992) NCAM: structural diversity, function and regulation of expression. Semin Cell Biol 3:189-197.
14. Gottlicher M, Minucci S, Zhu P, Kramer OH, Schimpf A, Giavara S, Sleeman JP, Lo Coco F, Nervi C, Pelicci PG, et al. (2001) Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO (Eur Mol Biol Organ) J 20:6969-6978.
15. Hauck RS and Nau H (1992) The enantiomers of the valproic acid analogue 2-n-propyl-4-pentynoic acid (4-yn-VPA): asymmetric synthesis and highly stereoselective teratogenicity in mice. Pharm Res 9:850-855.
16. He TC, Chan TA, Vogelstein B, and Kinzler KW (1999) PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99:335-345.
17. Lampen A, Carlberg C, and Nau H (2001a) Peroxisome proliferator-activated receptor delta is a specific sensor for teratogenic valproic acid derivatives. Eur J Pharmacol 431:25-33.
18. Lampen A, Gottlicher M, and Nau H (2001b) Prediction of embryotoxic effects of valproic acid-derivatives with molecular in vitro methods. Altex 18:123-126.
19. Lampen A, Meyer S, and Nau H (2001c) Phytanic acid and docosahexaenoic acid increase the metabolism of all-trans-retinoic acid and CYP26 gene expression in intestinal cells. Biochim Biophys Acta 1521:97-106.
20. Lampen A, Siehler S, Ellerbeck U, Gottlicher M, and Nau H (1999) New molecular bioassays for the estimation of the teratogenic potency of valproic acid derivatives in vitro: activation of the peroxisomal proliferator-activated receptor (PPARdelta). Toxicol Appl Pharmacol 160:238-249.
21. Lee CH, Chawla A, Urbiztondo N, Liao D, Boisvert WA, Evans RM, and Curtiss LK (2003) Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science (Wash DC) 302:453-457.
22. Michalik L, Desvergne B, and Wahli W (2003) Peroxisome proliferator-activated receptors beta/delta: emerging roles for a previously neglected third family member. Curr Opin Lipidol 14:129-135.
23. Muhlenhoff M, Eckhardt M, and Gerardy-Schahn R (1998) Polysialic acid: three-dimensional structure, biosynthesis and function. Curr Opin Struct Biol 8:558-564.
24. Murakami S, Seki T, Rutishauser U, and Arai Y (2000) Enzymatic removal of polysialic acid from neural cell adhesion molecule perturbs the migration route of luteinizing hormone-releasing hormone neurons in the developing chick forebrain. J Comp Neurol 420:171-181.
25. Nau H, Hauck RS, and Ehlers K (1991) Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms. Pharmacol Toxicol 69:310-321.
26. Ong E, Nakayama J, Angata K, Reyes L, Katsuyama T, Arai Y, and Fukuda M(1998) Developmental regulation of polysialic acid synthesis in mouse directed by two polysialyltransferases, PST and STX. Glycobiology 8:415-424.
27. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, and Klein PS (2001) Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer and teratogen. J Biol Chem 276:36734-36741.
28. Rutishauser U (1998) Polysialic acid at the cell surface: biophysics in service of cell interactions and tissue plasticity. J Cell Biochem 70:304-312.
29. Rutishauser U, Acheson A, Hall AK, Mann DM, and Sunshine J (1988) The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science (Wash DC) 240:53-57.
30. Rutishauser U and Landmesser L (1996) Polysialic acid in the vertebrate nervous system: a promoter of plasticity in cell-cell interactions. Trends Neurosci 19:422-427.
31. Sabath DE, Broome HE, and Prystowsky MB (1990) Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte. Gene 91:185-191.
32. Seki T and Arai Y (1991) The persistent expression of a highly polysialylated NCAM in the dentate gyrus of the adult rat. Neurosci Res 12:503-513.
33. Skladchikova G, Berezin V, and Bock E (1998) Valproic acid, but not its non-teratogenic analogue 2-isopropylpentanoic acid, affects proliferation, viability and neuronal differentiation of the human teratocarcinoma cell line NTera-2. Neurotoxicology 19:357-370.
34. Sumanasekera WK, Tien ES, Davis JW 2nd, Turpey R, Perdew GH, and Vanden Heuvel JP (2003) Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor-alpha (PPARalpha) and PPARbeta activity. Biochemistry 42:10726-10735.
35. Svensson K, Mattson R, James T, Wntzel P, Olsson T, Eriksson U, and Ohlsson R (1998) The paternal allele of the H19 gene is progressively silenced during early mouse development: the acetylation status of histones may be involved in the generation of variegated expression patterns. Development 125:61-69.
36. Takashima S, Yoshida Y, Kanematsu T, Kojima N, and Tsuji S (1998) Genomic structure and promoter activity of the mouse polysialic acid synthase (mST8Sia IV/PST) gene. J Biol Chem 273:7675-7683.
37. Thiery JP, Duband JL, Rutishauser U, and Edelman GM (1982) Cell adhesion molecules in early chicken embryogenesis. Proc Natl Acad Sci USA 79:6737-6741.
38. Werling U, Siehler S, Litfin M, Nau H, and Gottlicher M (2001) Induction of differentiation in F9 cells and activation of peroxisome proliferator- activated receptor δ by valproic acid and its teratogenic derivatives. Mol Pharmacol 59:1269-1276.
39. Yang P, Major D, and Rutishauser U (1994) Role of charge and hydration in effects of polysialic acid on molecular interactions on and between cell membranes. J Biol Chem 269:23039-23044.
40. Zhang J, Hagopian-Donaldson S, Serbedzija G, Elsemore J, Plehn-Dujowich D, McMahon AP, Flavell RA, and Williams T (1996) Neural tube, skeletal and body wall defects in mice lacking transcription factor AP-2. Nature (Lond) 381:238-241.